comparemela.com

Latest Breaking News On - Clarius group - Page 1 : comparemela.com

Forefront Analytics LLC Grows Stake in Athira Pharma, Inc. (NASDAQ:ATHA)

Forefront Analytics LLC grew its holdings in shares of Athira Pharma, Inc. (NASDAQ:ATHA – Free Report) by 43.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,765 shares of the company’s stock after purchasing an additional 8,955 shares during the […]

Athira-pharma
Nan-fung-group-holdings-ltd
Athira-pharma-inc
Forefront-analytics
Exchange-commission
Advisor-group
Clarius-group
Laird-norton-trust-company
Nasdaq
Barclays-plc
Free-report
Norton-trust-company

Bell Asset Management Ltd Sells 1,658 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Bell Asset Management Ltd reduced its stake in Mettler-Toledo International Inc. (NYSE:MTD – Free Report) by 17.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,027 shares of the medical instruments supplier’s stock after selling 1,658 shares during the period. Mettler-Toledo International makes […]

Switzerland
China
Chinese
Swiss
Shawn-vadala
Stifel-nicolaus
Christian-magloth
News-ratings-for-mettler-toledo-international-daily
Mettler-toledo-international-stock-performance
Jefferies-financial-group
Clarius-group
Securities-exchange-commission

Athira Pharma, Inc. (NASDAQ:ATHA) Sees Large Drop in Short Interest

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totalling 923,300 shares, a drop of 12.1% from the April 30th total of 1,050,000 shares. Currently, 2.6% of the company’s shares are sold short. Based on an […]

Athira-pharma
Laird-norton-trust-company
Athira-pharma-inc
Forefront-analytics
Advisor-group
Clarius-group
Nasdaq
Athira-pharma-company-profile
Get-free-report
Capital-partners
Norton-trust-company
Pharma-stock-down

Athira Pharma, Inc. (NASDAQ:ATHA) Short Interest Down 12.1% in May

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 923,300 shares, a drop of 12.1% from the April 30th total of 1,050,000 shares. Based on an average daily trading volume, of 309,500 […]

Athira-pharma
Laird-norton-trust-company
Clarius-group
Advisor-group
Forefront-analytics
Athira-pharma-inc
Athira-pharma-company-profile
Nasdaq
Get-free-report
Capital-partners
Norton-trust-company
Pharma-stock-down

Crestline Management LP Buys 14,674 Shares of Sempra (NYSE:SRE)

Crestline Management LP boosted its stake in Sempra (NYSE:SRE – Free Report) by 14.0% during the 4th quarter, Holdings Channel reports. The firm owned 119,174 shares of the utilities provider’s stock after buying an additional 14,674 shares during the quarter. Crestline Management LP’s holdings in Sempra were worth $8,906,000 at the end of the most […]

United-states
Karenl-sedgwick
Sandy-spring-bank
Benjamin-edwards-inc
Mechanics-bank-trust-department
Clarius-group
Wells-fargo-company
Holdings-channel
Advisornet-financial-inc
Morgan-stanley
Barclays

vimarsana © 2020. All Rights Reserved.